| REGN Snapshot | |
|---|---|
| Regeneron Pharmaceuticals, Inc. is an American biotechnology company headquartered in Westchester County, New York. Originally focused on neurotrophic factors and their regenerative capabilities, giving rise to its name, the company then branched out into the study of both cytokine and tyrosine kinase receptors. | |
| VALUATION DATA | |
| Market Capitalization | $88,846,279,000 | Price to Sales | 6.76 |
| Earnings per Share | $35.0800 |
| PE Ratio | 23.25 |
| PRICE DATA | |
| Most Recent Close | $820.9000 |
| 52 Week High | $853.97 |
| 52 Week Low | $668 |
| 50-Day Moving Average | $813.09 |
| 200-Day Moving Average | $784.84 |
| All data are from Alpha Vantage as of today. For more infomation on REGN see Stock Dividend, Valuation, Price and Financial Data for Investors | |
Custom Search